Neos Therapeutics

Speciality Company developing extended release drugs for CNS disorders using proprietary technology platform

placeGrand Prairie, Texas, United States calendar_todayFounded 2008 groups150 employees language neostx.com

Registered entities

Investor mix

9 investors on record; lead investors include Delaware Street Capital, Presidio Partners, Essex Capital.

Investor typeCountShare
Venture capital222%
Private equity111%
Bank & private debt222%
Other / undisclosed444%
Coming soon